ArticleDrug design, development and therapy2020

Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.

Hadi Zare-Zardini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.